CHAPEL HILL, N.C., July 26, 2013 /PRNewswire/ --Recent pharmaceutical industry product launches have had uneven results, marked by launch success or failure factors. In the Oncology therapy area, in particular, utilizing new product launch success and failure guidelines can play a significant role in a launch's outcome.
In order to help launch leaders to effectively plan market entry strategies for their pipeline oncology products, benchmarking firm Best Practices, LLC developed a research report. The study, "Success Factors and Failure Points in Oncology Product Launches," delves deeper into the area of therapeutic product launches and identifies lessons learned, pitfalls and winning strategies of leaders in the Oncology therapeutic area.
The benchmarking report also addresses key issues that are integral to the success of a new product. Some key insights, best practices, and pitfalls harvested focused on:
- Winning on Differentiated Product Positioning
- Winning a Physician's Initial Trial of a New Product
- Articulating Benefits that Shape Positive Market Perception
- New Product Pricing Strategy
- Thought Leader Engagement
- Early Physician Education
- Payer Education
- Patient Advocacy and Education
The 173-page report delivers hard-to-find benchmarks that will allow executives to better examine industry standards in various areas. The research drew participation from 44 executives and managers from 38 leading pharmaceutical, biotech and medical device companies. In addition, field commentaries and insights were gained from 17 executives involved in launches.
To access the full report, or to download a complimentary summary containing insights found in this report, click on the following link: http://www.best-in-class.com/rr1225.htm.
For more information on this study or other recent primary research studies, contact us at 919.403.0251 or to learn more about best practices in new product launches and other benchmarking insights, visit our website at http://www.best-in-class.com.
ABOUT BEST PRACTICES, LLC
Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations. Best Practices, LLC believes in the profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies.
SOURCE Best Practices, LLC
